CWG
C WorldWide Group Portfolio holdings
AUM
$7.38B
This Quarter Return
+9.48%
1 Year Return
+18.35%
3 Year Return
+71.53%
5 Year Return
+105.42%
10 Year Return
+360.65%
AUM
$8.89B
AUM Growth
+$8.89B
(+3.8%)
Cap. Flow
-$394M
Cap. Flow
% of AUM
-4.44%
Top 10 Holdings %
Top 10 Hldgs %
74.41%
Holding
100
New
18
Increased
19
Reduced
27
Closed
7
Top Buys
| 1 |
S&P Global
SPGI
|
$249M |
| 2 |
QuidelOrtho
QDEL
|
$32.9M |
| 3 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$10.6M |
| 4 |
Mondelez International
MDLZ
|
$9.53M |
| 5 |
Exact Sciences
EXAS
|
$9.4M |
Top Sells
| 1 |
MSCI
MSCI
|
$248M |
| 2 |
Alibaba
BABA
|
$248M |
| 3 |
Amazon
AMZN
|
$108M |
| 4 |
TSMC
TSM
|
$29.1M |
| 5 |
HDFC Bank
HDB
|
$27.9M |
Sector Composition
| 1 | Consumer Discretionary | 18.57% |
| 2 | Financials | 17.04% |
| 3 | Healthcare | 16.43% |
| 4 | Consumer Staples | 10.86% |
| 5 | Technology | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
CVS Health
CVS
$92.8B
| $30.1M | 0.34% | 516,015 | – | – |
|
27
Intuitive Surgical
ISRG
$170B
| $29.8M | 0.33% | 41,937 | – | – |
|
28
New Oriental
EDU
$7.85B
| $27.4M | 0.31% | 183,213 -848 | -0.5% | -$127K |
|
29
Edwards Lifesciences
EW
$47.8B
| $27.2M | 0.31% | 341,311 +54,070 | +19% | +$4.32M |
|
30
NovoCure
NVCR
$1.38B
| $26.9M | 0.3% | 241,784 -100,000 | -29% | -$11.1M |
|
31
DexCom
DXCM
$29.5B
| $25.6M | 0.29% | 62,000 | – | – |
|
32
Centene
CNC
$14.3B
| $24.2M | 0.27% | 414,756 -71,702 | -15% | -$4.18M |
|
|
LHCG
33
DELISTED
LHC Group LLC
LHCG
| $23.5M | 0.26% | 110,657 -25,000 | -18% | -$5.31M |
|
|
AXNX
34
DELISTED
Axonics, Inc. Common Stock
AXNX
| $20.4M | 0.23% | 400,000 | – | – |
|
35
Sarepta Therapeutics
SRPT
$1.78B
| $20.4M | 0.23% | 145,329 | – | – |
|
36
TAL Education Group
TAL
$6.46B
| $20.4M | 0.23% | 268,352 -1,758 | -0.7% | -$134K |
|
37
Teleflex
TFX
$5.59B
| $19.7M | 0.22% | 58,000 +5,000 | +9% | +$1.7M |
|
38
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $19.4M | 0.22% | 1,058,464 +150,000 | +17% | +$2.75M |
|
39
Vertex Pharmaceuticals
VRTX
$100B
| $18.7M | 0.21% | 68,557 | – | – |
|
40
Illumina
ILMN
$15.8B
| $17.9M | 0.2% | 57,978 | – | – |
|
41
Insulet
PODD
$23.9B
| $17.2M | 0.19% | 72,908 | – | – |
|
|
AERI
42
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $17.1M | 0.19% | 1,456,142 +900,000 | +162% | +$10.6M |
|
|
BHVN
43
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $16.4M | 0.18% | 251,751 +50,000 | +25% | +$3.25M |
|
|
MYOK
44
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $15.9M | 0.18% | 116,950 | – | – |
|
45
Merck
MRK
$210B
| $15.5M | 0.17% | 186,728 | – | – |
|
46
Insmed
INSM
$28.8B
| $14.2M | 0.16% | 443,110 | – | – |
|
47
Heron Therapeutics
HRTX
$207M
| $13.4M | 0.15% | 902,069 +200,000 | +28% | +$2.96M |
|
48
BioMarin Pharmaceuticals
BMRN
$11.2B
| $12.5M | 0.14% | 163,851 | – | – |
|
49
Glaukos
GKOS
$5.5B
| $12.2M | 0.14% | 247,212 | – | – |
|
50
TherapeuticsMD
TXMD
$12.8M
| $9.78M | 0.11% | 6,189,834 | – | – |
|